The FDA's drug approval rate plunged in 2016

The FDA's drug approval rate was down in 2016.
(Image credit: Getty Images)

2016 was not a good year for new medicines. The U.S. Food and Drug Administration cleared just 22 new drugs for sale last year, the lowest number since 2010 and a sharp decline from 2015's total of 45 approved drugs. While the FDA simply delayed approval on some applications that will likely be given the green light in 2017, there's also been a decline in applications overall, Reuters reports. Despite recent advances in cancer treatment and other genetic diseases, drug companies are finding difficulty securing financial returns due to political pushback against the rising costs of medicine. Returns on research and development investment at the top 12 pharmaceutical companies fell to 3.7 percent in 2016, from a high of 10.1 percent in 2010.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us